Livelsberger Financial Advisory’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-159
Closed -$1.54K 59
2025
Q2
$1.54K Buy
+159
New +$1.64K 0.03% 71
2024
Q4
Sell
-134
Closed -$2.56K 56
2024
Q3
$2.56K Buy
+134
New +$2.78K 0.05% 64
2024
Q1
Sell
-130
Closed -$1.88K 146
2023
Q4
$1.88K Buy
+130
New +$1.77K ﹤0.01% 400

Other funds holding OGN

Livelsberger Financial Advisory's OGN Position: Q3 2025 in Review

Livelsberger Financial Advisory sold out of Organon & Co (OGN) in Q3 2025, closing a stake of 159 shares — an estimated $1.54K sold.

Livelsberger Financial Advisory first reported a position in OGN in Q4 2023 and held it in 3 quarters. The position peaked at $2.56K in Q3 2024. 670 funds tracked by Wall St. Rank hold OGN as of Q3 2025.

  • Livelsberger Financial Advisory reported no remaining Organon & Co position as of Q3 2025 after selling out during the quarter.
  • Livelsberger Financial Advisory sold 159 Organon & Co shares in Q3 2025, an estimated $1.54K.
  • Livelsberger Financial Advisory first reported a position in Organon & Co in Q4 2023 and held it in 3 quarters.
  • Livelsberger Financial Advisory's Organon & Co position peaked at $2.56K in Q3 2024.
  • 670 funds tracked by Wall St. Rank held Organon & Co as of Q3 2025.

Based on Livelsberger Financial Advisory's 13F filing for Q3 2025, filed 14 Oct 2025.